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Intrarenal hypoxia develops within a few days after the onset of insulinopenic diabetes in an experimental
animal model (ie, a model of type-1 diabetes). Although diabetes-induced hypoxia results in increased renal
lactate formation, mitochondrial function is well maintained, a condition commonly referred to as pseudohy-
poxia. However, the metabolic effects of significantly elevated lactate levels remain unclear. We therefore
investigated in diabetic animals the response to acute intrarenal hypoxia in the presence of high renal lac-
tate formation to delineate mechanistic pathways and compare these findings to healthy control animals. Hy-
perpolarized 13C-MRI and blood oxygenation level–dependent 1H-MRI was used to investigate the renal me-
tabolism of [1-13C]pyruvate and oxygenation following acutely altered oxygen content in the breathing gas
in a streptozotocin rat model of type-1 diabetes with and without insulin treatment and compared with
healthy control rats. The lactate signal in the diabetic kidney was reduced by 12%–16% during hypoxia in
diabetic rats irrespective of insulin supplementation. In contrast, healthy controls displayed the well-known
Pasteur effect manifested as a 10% increased lactate signal following reduction of oxygen in the inspired air. Re-
duced expression of the monocarboxyl transporter-4 may account for altered response to hypoxia in diabetes
with a high intrarenal pyruvate-to-lactate conversion. Reduced intrarenal lactate formation in response to hypoxia
in diabetes shows the existence of a different metabolic phenotype, which is independent of insulin, as insulin
supplementation was unable to affect the pyruvate-to-lactate conversion in the diabetic kidney.
INTRODUCTION
In the diabetic kidney, hyperglycemia activates primarily mito-
chondrial uncoupling and secondarily the production of reac-
tive oxygen species, which reduces energy production and cre-
ates hypoxia and an increased oxygen sensitivity in the kidney
(1-5). Lactate dehydrogenase (LDH) and pyruvate dehydroge-
nase (PDH) are key enzymes in the pyruvate metabolism, thus
facilitating pyruvate conversion to lactate or acetyl coenzyme
A. Acetyl coenzyme A is the entry into Krebs cycle and follows
the mitochondrial respiratory chain. An unchanged PDH activ-
ity indicates sufficient oxygen supply to the diabetic kidney,
while hypoxia causes an elevated lactate pool and possibly a
reduced PDH activity (1, 6, 7).
Magnetic resonance imaging (MRI) is considered an impor-
tant functional imaging method for clinical decision-making in
patients with renal disease (8-11), as well as in preclinical
animal studies (12-15). Particularly important to assess the met-
abolic balance (PDH versus LDH) are the blood oxygenation
level–dependent (BOLD) method and the metabolic imaging
approach referred to as hyperpolarized 13C-based magnetic res-
onance (MR) spectroscopy (5, 16-19). The combination of these
2 methods enables longitudinal assessment of oxygen availabil-
ity in parallel with PDH ([1-13C]pyruvate-to-13C-bicarbonate
conversion) and LDH ([1-13C]pyruvate-to-[1-13C]lactate conver-
sion) flux estimation directly in the kidney tissue in vivo (5).
Previous studies have shown high and unaltered pyruvate-to-
lactate conversion in the early diabetic kidney (3, 5, 20-24). This
pyruvate-to-lactate conversion has previously been correlated
with the severity of diabetic renal complications toward diabetic
nephropathy (25). Interestingly, diabetic rats with similar pyru-
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vate-to-lactate conversion to healthy controls under normoxic
conditions showed an increased pyruvate-to-lactate conversion
following acute reduction in the respired oxygen content (3).
Moreover, treatment with insulin increased the overall meta-
bolic conversion (not sufficient to maintain good glycemic con-
trol), including increased pyruvate-to-lactate conversion (20).
These discrepancies seem to suggest either a large variation in
the streptozotocin model or potential distinct metabolic pheno-
types. In this study, we investigated the metabolism of diabetic
rats exhibiting increased pyruvate-to-lactate conversion com-
pared with previous reports at similar time points and similar
conditions (2 weeks of diabetes), although similar or even less
pronounced diabetic complications and as such represent a
naturally occurring phenotype or variation with unknown ori-
gin. We study the response to acutely altered oxygen supply
[66% O2, sufficient oxygen to ensure fully saturated blood
versus 10% O2, low oxygen content similar to previous report
(3)], with and without insulin supplementation. We test the
hypothesis that severe pseudohypoxia [highly elevated lactate-
to-pyruvate ratio compared with controls and aforementioned
previous reports at 2 weeks (3, 20)] is unable to compensate the
lack of oxygen by increasing the intracellular lactate and thus is
exhibiting an alternative metabolic phenotype.
METHODOLOGY
Animals and Study Protocol
Twenty-two 8-week-old female Wistar rats (N  7–8/group;
Taconic, Ry, Denmark) were included in this study. The rats were
kept in cages with a 12:12-h light–dark cycle, temperature of
21°C 2°C and a humidity of 55% 5%. Diabetes was induced
by an intravenous injection of freshly prepared streptozotocin
(55 mg/kg body weight; Sigma-Aldrich, St. Louis, MO) dissolved
in 10 mmol/L cold citrate buffer (pH 4.5). Blood glucose was
measured in tail capillary blood with a Contour blood glucose
meter (Bayer Diabetes Care, Copenhagen, Denmark). Rats were
considered diabetic when the blood glucose levels exceeded 15
mmol/L at 48 h after injection of streptozotocin. The rats were
divided into a diabetes group and treated group after 1.5 weeks
of diabetes. NPH insulin (Eli Lilly, IN) was administered subcu-
taneous daily for 3 days (1 IU morning and 3 IU afternoon)
before the MRI examination. On the day of the MRI examina-
tion, the rats received 1 IU in the morning 2–4 h before the MRI
scan. The study complied with the guidelines for use and care of
laboratory animals and was approved by the Danish Inspector-
ate of Animal Experiments (License: 2010/561-1938).
Colorimetric Assays
Assays to measure LDH and PDH activity and the absolute
amount of lactate were performed according to manufacturer’s
instructions (Sigma-Aldrich, St. Louis, MO). The assays were
performed on homogenized tissue samples dissolved in buffer
from each of the respective assays, derived from cortical kidney
biopsies. Biopsies were obtained at the time of sacrifice and
stored in 80°C. Absorbance was measured in 384 Costar well
plates using a PHERAstar FS microplate reader (BMG Labtech,
Birkerød, Denmark). In a full spectrum test screen, we found that
the optimal wavelength was 662 nm for LDH, PDH, and lactate.
The calculated activities were normalized to protein content
in the kidney sample. Protein content was determined using a
Qubit 3.0 fluorometer (Life Technologies, Thermo Fisher Scien-
tific, Hvidovre, Denmark).
RNA Extraction and Quantitative Polymerase Chain
Reaction
RNA extraction and qPCR were performed. In brief, total RNA
was isolated using a Nucleospin RNA II kit (Strategene, AH
Diagnostics, Aarhus, Denmark) following manufacturer’s in-
structions. We measured RNA purity and concentration using a
Qubit 3.0 fluorometer (Life Technologies). cDNA synthesis was
performed on 0.5-g RNA with the RevertAid first-strand cDNA
synthesis kit following manufacturer’s instructions (Thermo
Fisher Scientific). Samples for qPCR were prepared using Max-
ima SYBR Green Master Mix following manufacturer’s instruc-
tions (Thermo Fisher Scientific). The qPCR protocol comprised
40 cycles of denaturation for 30 seconds at 95°C followed by
annealing and synthesis for 1 minute at 60°C. Rat primer se-
quences used are described in Table 1. As mentioned, kidneys
were rapidly dissected after sacrifice. Cortex and inner me-
dulla were isolated to tubes and dumped in liquid nitrogen
and stored in 80°C. Cortex biopsies were homogenized for
RNA extraction.
[1-13C]Pyruvate Hyperpolarization
A volume of 20-L [1-13C]pyruvic acid (Sigma Aldrich) con-
taining 15mM OX063 (Oxford Instruments, Oxford, UK) and 1.5
mmol/L Dotarem (Guerbet, Villepinte, France) was inserted into
a dissolution-DNP HyperSense polarizer (Oxford Instruments
Molecular Biotools, Oxford, UK). The sample was polarized for
Table 1. RT-PCR Primer Sequences
Gene Forward Sequence Reverse Sequence
Rat 18S 5=-CAT GGC CGT TCT TAG TTG-3= 5=-CAT GCC AGA GTC TCG TTC-3=
Rat PDH-A1 5=-TCC ACT CCT TGT AGC TGC AAC-3= 5=-GAG AAC CCA CCA CCC CAT G-3=
Rat LDH-A 5=-GCC ATG TAT TCC TTC CCT CA-3= 5=-GCC TCA TTG AAG ACC TGC TC-3=
Rat ALT 5=-GCC ATG TAT TCC TTC CCT CA-3= 5=-GCC TCA TTG AAG ACC TGC TC-3=
Rat MCT-1 5=-CTC TGG GCG CCG CGA GAT AC-3= 5=-CAA CTA CCA CCG CCC AGC CC-3=
Rat MCT-4 5=-CCA GGC CCA CGG CAG GTT TC-3= 5=-GCC ACC GTA GTC ACT GGC CG-3
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1 h at 94.118 GHz (100 mW). The hyperpolarized sample was
dissolved in 4 mL of a dissolution medium (80 mmol/L TRIS, 100
mg/L EDTA, 50 mmol/L NaCl, 80 mmol/L NaOH), yielding an
isotonic 80 mmol/L [1-13C]-pyruvate solution at physiological
pH. The sample temperature after dissolution was 30°C–35°C,
resulting in a reproducible polarization of 30% and a T1 in the
range of 40–60 seconds (26). A volume of 1.0 mL was injected
into the tail vein over 10 seconds. The transfer time between
dissolution and injection was 10 seconds on average, and the
13C chemical shift imaging (CSI) MR-sequence was initiated 20
seconds after start of injection.
Magnetic Resonance Imaging and Spectroscopy
Two weeks after induction of diabetes, tail vein catheterization
was performed for administration of hyperpolarized [1-13C]py-
ruvate. The animal was placed in a 4.7 T Agilent MR scanner
with VnmrJ 4.0 (Agilent, Santa Clara, CA) that was equipped
with a dual-tuned 1H/13C volume transmit and a 4-channel
array surface receive-coil (Rapid Biomedical, Würzburg, Ger-
many). The protocol (Figure 1) consists of 2 baseline scans (1H
BOLD MRI and a 13C magnetic resonance spectroscopy [MRS])
during hyperoxic breathing with 66% oxygen content (0.8%
isoflurane, 0.66 L/min oxygen, and 0.34 L/min nitrogen) and 2
postinterventions scans (1H BOLD MRI and a 13C MRS) with a
10% oxygen content (15 minutes of 0.8% isoflurane, 0.10 L/min
oxygen, and 0.90 L/min nitrogen). Temperature and respiration
were monitored. After the MRI session, a 5- to 7-mL blood
sample was collected from the aortic bifurcation to EDTA-
coated tubes for determination of plasma electrolytes.
MRI and MRS sequence parameters were as follows. An
oxygenation-dependent (T2*-weighted) sequence was per-
formed using an axial 1H multiecho gradient-echo sequence.
The sequence parameters were: matrix  128  128, field of
view (FOV)  60  60 mm2, flip angle  30°, repetition time
(TR)  300 milliseconds, number of transients  16, echo time
(TE)  2, 4, 6, 8, 10, 12, 14, 16 milliseconds, slices  3, slice
thickness  5 mm, covering both kidneys. A scout 1H axial
gradient echo sequence (matrix  128  128, FOV  60  60
mm2, TR/TE  100 ms/2.6 ms, flip angle  20°, averages  16,
slices  7, slice thickness  3 mm, covering both kidneys) was
acquired for anatomical overlay. A slice-selective 2D 13C chem-
ical-shift imaging sequence was used for hyperpolarized [1-
13C]-pyruvate imaging. Parameters were chosen to be similar to
previous studies in the same animal model (4, 20): flip angle 
10°, a centric circular k-space trajectory (169 phase encodings),
TR/TE 75 ms/0.65 ms, FOV 60 60 mm2, spectral width
4000 Hz, data sampling  256 complex points, and an axial
slice thickness  20 mm, covering both kidneys.
MRI Analysis
Data analysis of BOLD MRI data was performed in VnmrJ 4.0,
generating R2* maps. CSI data were processed in Matlab (Math-
Works, Natick, MA). Spatial dimensions were apodized with a
hamming function and zero-filled to a 32 32 grid. The spectral
dimension was centered on the pyruvate frequency; apodized
with a zero shifted sine-bell function and a 5-Hz exponential
line broadening; and processed as sum-of-squares of the four
coil channels. Spectral analysis was performed on a single voxel
placed inside the kidney. Metabolite signals were integrated
over a 60-Hz symmetric region. The metabolite signals were
normalized relative to the total carbon signal.
Statistical Analyses
Normality was assessed with quantile plots. P  .05 was con-
sidered statistically significant. A 2-way repeated measurement
analysis of variance (ANOVA) was used to compare the meta-
bolic response as a function of oxygen availability between the
three groups, using Sidak corrections for multiple comparisons.
Statistical analysis was performed in PRISM. Statistical analysis
of animal, kidney weight and blood glucose were analyzed with
a 1-way ANOVA, while HbA1c between the diabetics and the
diabetics receiving insulin was analyzed using a 2-tailed Stu-
dent t test with equal variance. The intrarenal lactate concen-
tration variance was analyzed using a Brown–Forsyth test of
variance.
RESULTS
All diabetic rats developed sustained hyperglycemia within 48 h.
Body weight, kidney weight, and long-term glucose level HbA1c
were comparable between diabetes and insulin-treated groups
(Table 2). Renal oxygen availability depended on the inspired
oxygen content, and BOLD MRI showed a significantly de-
creased T2* in the renal cortex in all groups following a reduc-
tion in the oxygen content of the breathing gas (diabetes group,
diabetes  insulin group, and control group) (P  .001) (Figure
2). The medullary T2* was inversely correlated with oxygen
content in the breathing gas in both the diabetes group (P 
.0009) and in the diabetes  insulin group, albeit the latter did
not reach significance (P  .087) (Figure 2). On the other hand,
T2* was unaffected by altered oxygen availability in the control
group (P  .96) (Figure 2). Both untreated diabetic (P  .001)
and insulin-treated diabetic (P  .001) rats had an overall
increased lactate production (lactate-to-total carbon ratio) in
the kidneys compared with healthy controls. In both the
untreated diabetes group (P  .001) and the insulin-treated
diabetes group (P .004), we found a decreased lactate-to-total
carbon ratio in response to decreased oxygen availability, while
the healthy controls (P .035) showed a significantly increased
lactate-to-total carbon ratio in response to decreased oxygen
availability (Figure 3). The alanine and the bicarbonate-to-total
carbon ratios were unaffected by altered oxygen supply in all
groups (Figure 3). The pyruvate-to-total carbon ratio increased
after administration of a low oxygen content in the diabetes
group compared with controls (P  .001), and similar findings
were found in the diabetes  insulin group (P  .001), while a
tendency toward a decreased pyruvate signal was observed in
the diabetes insulin group (P .070) (Figure 3). A statistically
significant variance (Brown–Forsyth test, P  .040) was found
in renal lactate concentration among the groups, indicating a
significantly elevated lactate concentration in the 2 diabetes
groups compared with controls (Figure 4).
A statistically significant difference in lactate dehydroge-
nase activity was found between both diabetes groups and the
control group (P  .001), with the highest activity seen in the
diabetes insulin group, while no difference in LDH expression
was seen between any of the groups (Figure 4). No difference
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Figure 1. Study protocol (A). All animals were exposed to either 66% oxygen content or 10% oxygen content in the breathing
gas. Blood oxygen level–dependent (BOLD) scan is performed 10 minutes after the change of oxygen content followed by a hyper-
polarized 13C pyruvate scan 20 minutes thereafter. Hyperpolarized 13C chemical shift imaging (CSI) image of a healthy control
animal and accompanying kidney spectra from the green region of interest (ROI) (B). Hyperpolarized 13C CSI image of a untreated
diabetic animal and accompanying kidney spectra from the green ROI (C). Hyperpolarized 13C CSI image of an insulin-treated
diabetic animal and accompanying kidney spectra from the green ROI (D).
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was seen in the lactate-to-bicarbonate, lactate-to-alanine, and
alanine-to-bicarbonate ratios in untreated and insulin-treated
diabetic rats during inspiration of 66% and 10% oxygen in the
breathing gas (Figure 5). The pyruvate dehydrogenase activity
increased in the untreated diabetes group, while the PDH
expression was significantly decreased in both diabetes
groups (Figure 6). Monocarboxylate transporters (MCT1) was
found to be similar in all groups (P .27), whereas MCT4 was
found to be significantly reduced in both diabetes groups
(P  .001) (Figure 6).
DISCUSSION
We have previously reported that the diabetic kidney responded
with a pronounced increase in lactate formation following re-
duced oxygen availability compared with healthy controls (3).
The decreased lactate formation in response to low oxygen
availability observed in the present study is likely explained by
the severity of diabetic nephropathy and the more increased
lactate level (80% increased pyruvate-to-lactate conversion
compared with previous reports (3, 20). The underlying mech-
anism for this altered metabolic phenotype is believed to
originate from the altered expression of MCT4 in the diabetic
rat kidney (dramatically downregulated) in response to pro-
found lactate accumulation similar to what is observed in
response to prolonged hypoxia (27). MCT1 controls the influx
of lactate, whereas MCT4 ensures redox balance by export of
lactate. Restricting lactic acid efflux from renal cells (main-
tained or reduced MCT4 expression) in concern with in-
creased intracellular lactic acid accumulation, leading to an
increased hyperpolarized [1-13C]pyruvate-to-[1-13C]lactate
conversion (increased MCT1 expression in diabetes), might be
a preventive mechanism to avoid systemic lactic acidosis, as
seen in muscles, where an intracellular accumulation of lactic
acid and subsequent altered redox state will inhibit glycolysis
and induce muscle fatigue before systemic alterations to the
pH regulation of the body (27, 28). Indeed mild acidosis has
recently been associated with an altered metabolic phenotype in
postmitotic cells, overriding oxygen deprivation and thus main-
taining mitochondrial function (29). Taken together, an altered
MCT transport is essential to the metabolic phenotype seen in
diabetes, and an altered efflux of lactate could be the origin of this
counterintuitive oxygen reversed oxygen sensitivity.
Table 2. Animal Characteristics
Body Weight
(g)
Kidney Weight
(g)
Blood Glucose
(mmol/L) HbA1c (%)
Control 222  7 0.8  0.1 8.6  0.7 Not measured
Diabetes 213  20 1.1  0.1a 23.8  3.8a 11.4  1.5
Diabetes  Insulin 200  26 1.1  0.2a 21.0  4.0a 12.3  0.7
aP  0.05 versus control. The blood glucose level is the average blood glucose of the 2 measurements performed in each rat. Values are represented as mean  SD.
Comparisons analyzed using 1-way ANOVA and Student t test.
Control Diabetes Diabetes+Insulin
0.000
0.005
0.010
0.015
0.020
Co
rti
ca
l T
2*
 [s
]
p=0.0093
p=0.0342
66% 10% 66% 10% 66% 10%
Control Diabetes Diabetes+Insulin
0.000
0.005
0.010
0.015
0.020
M
ed
ul
la
ry
 T
2*
 [s
]
p=0.0026
66% 10% 66% 10% 66% 10%
A B
Figure 2. BOLD magnetic resonance imaging (MRI) in cortex and medulla of controls and untreated and insulin-treated
diabetic rats during inspiration of 66% and 10% oxygen in the breathing gas. (Cortical T2*) P  .68 for group (be-
tween healthy controls and untreated and insulin-treated diabetic rats), P  .0001* for treatment (inspired oxygen), and
P  .81 for interaction (A). (Medullary T2*) P  .08 for group (between healthy controls and untreated and insulin-
treated diabetic rats), P  .005* for treatment (Inspired oxygen), and P  .04 for interaction* (B). Lines denote mean 
SEM. Two-way repeated ANOVA.
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Figure 3. Hyperpolarized lac-
tate, pyruvate, alanine, and bicar-
bonate signal to sum of the signal
ratios in controls and untreated
and insulin-treated diabetic rats
during inspiration of 66% and
10% oxygen in the inspired air.
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for group* (between healthy con-
trols and untreated and insulin-
treated diabetic rats), P  .002*
for treatment (inspired oxygen),
and P  .0007 for interaction*
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.43 for group (between healthy
controls and untreated and insulin-
treated diabetic rats), P  .15 for
treatment (inspired oxygen), and
P  .6 for interaction (B). (Pyru-
vate-to-signal) P  .001 for
group* (between healthy controls
and untreated and insulin-treated
diabetic rats), P  .002 for treat-
ment* (inspired oxygen), and P 
.05 for interaction* (C); (Bicar-
bonate-to-signal) P  .1 for
group* (between healthy controls
and untreated and insulin-treated
diabetic rats), P  .85 for treat-
ment* (inspired oxygen), and P 
.46 for interaction. Two-way re-
peated ANOVA (D).
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Figure 4. Colorimetric assay lactate dehydrogenase activity (P  .001) (A), qPCR lactate dehydrogenase mRNA ex-
pression (P  .787) (B), and colorimetric assay kidney tissue lactate concentration (P  .187) (C); significant variance
(Brown–Forsyth test, P  .04) was found between healthy controls and untreated and insulin-treated diabetic rats. One-
way ANOVA.
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We speculate that the altered lactate transport could be
active inhibition of the monocarboxylic transporters, as previ-
ously shown for the active mitochondrial pyruvate transporter
with -cyano-4-hydroxycinnamate (30) and in muscle tissue
where lactate uptake and efflux stimulate an increased lactate
concentration and altered intra- and extracellular pH (31).
Interestingly, the increased lactate-to-total carbon ratio in
the diabetic kidney occurred regardless of insulin supplementa-
tion, indicating that insulin did not affect the balance between
oxygen availability and energy metabolism in the hypoxic dia-
betic kidney. These findings support previous reports on in-
creased lactate production in the diabetic kidneys regardless of
Figure 5. Hyperpolarized lactate-to-bicarbonate, lactate-to-alanine, and alanine-to-bicarbonate signal ratios in un-
treated and insulin-treated diabetic rats during inspiration of 66% and 10% oxygen in the inspired air. (Lactate-to-
Bicarbonate) P  .73 for group (between healthy controls and untreated and insulin-treated diabetic rats), P  .98 for
treatment (inspired oxygen), and P  .06 for interaction (A). (Lactate-to-Alanine) P  .14 for group (between
healthy controls and untreated and insulin-treated diabetic rats), P  .78 for treatment (inspired oxygen), and P  .12
for interaction (B). (Alanine-to-bicarbonate) P  .32 for group (between healthy controls and untreated and insulin-
treated diabetic rats), P  .72 for treatment (Inspired oxygen), and P  .23 for interaction (C). Two-way repeated
ANOVA.
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Figure 6. (A) Colorimetric assay
pyruvate dehydrogenase activity
and (B) qPCR mRNA expressions
of pyruvate dehydrogenase; com-
parison of (C) monocarboxylate
transporter 1 (MCT1) and (D) 4
(MCT4) in healthy controls and
untreated and insulin-treated dia-
betics rats. One-way ANOVA.
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insulin treatment (20). However, these results also imply the
presence of different metabolic phenotypes occurring in diabe-
tes, as high intrarenal lactate levels significantly altered the
response to reduced oxygen availability in the diabetic animals
(3, 4, 20, 25). This finding might be explained by the need for the
high lactate-producing kidney to maintain homeostasis during
hypoxia as previously reported in cancer cells (32). Thus, acute
hypoxia in an already high lactate environment increases the
lactate-to-pyruvate conversion and/or reduces the pyruvate-to-
lactate conversion and thus maintains the intracellular redox
potential. It is unlikely that the difference in the metabolic
conversion is due to decreased conversion in diabetic rats, as the
pyruvate-to-total carbon ratio was lower (ie, more pyruvate is
being converted to its metabolic derivatives) in diabetics com-
pared with controls.
The increased pyruvate-to-lactate conversion may charac-
terize the severity of the deranged metabolism in the diabetic
kidney, as previously described by Lin et al. (33). However, the
increased lactate-to-pyruvate level found in the diabetic kidney
in this study was not directly linked to severity, and thus, the
altered response to oxygen supply may enable a further differ-
entiation of the metabolic phenotype by interrogating the un-
derlying mechanism, thus providing a window of opportunity
for pharmacologically targeting these metabolically different
phenotypes. In fact, recent studies have indicated that increased
glycolytic flux as a renal protective trait and thus the phenotype
seen here might be better protected against renal impairment
(34). The alanine-to-total carbon ratio, regulated by the alanine
transferase and linked via the cosubstrate glutamate and -ke-
toglutarate to the glutamine and fatty acid synthesis, is insen-
sitive to the changes in inhaled oxygen. This lack of oxygen
dependency indicates a generally sufficient oxygen availability
to maintain the increased mitochondrial fatty acid oxidation in
kidney tubular cells (35) and similarly the bicarbonate-to-total
carbon ratio that describes the oxidative phosphorylation via
the mitochondrial pyruvate dehydrogenase activity (2-4). The
oxygen-sensitive BOLD MRI showed hypoxia and increased
oxygen consumption. These measurements indicate that a gen-
eral deranged metabolism is inversely dependent on oxygen
availability in the severe pseudohypoxic diabetic kidney, both
with and without insulin treatment. Therefore, we suggest that
the sensitivity toward changes in oxygen supply defines an
alternative diabetic phenotype, indicating reduction in active
cellular uptake of pyruvate. A potential limitation in the study
design is the use of CSI for spatial localization of the metabo-
lites, limiting the spatial resolution and especially the temporal
resolution compared with faster or higher resolution imaging
methods (26, 36-39). Another limitation is the need for anes-
thetics, which have been shown to impact the renal metabolism
(40), although the used regime has only mild renal effects com-
pared with other anesthetic regimes. Insulin administration did
not alter the overall metabolic phenotype, which is supported by
previous studies in heart and kidneys (20, 41, 42). However, it is
important to note that the used insulin treatment was a dose
mimicking suboptimal insulin treatment similar to a previous
report (20), and as such, it is currently unknown what the impact
of adequate insulin administration for sufficient glycemic con-
trol would entail. Further, 66% oxygen was chosen to ensure
fully saturated blood, thus maximizing the potential differences
between hypoxia and hyperoxia. No difference was observed
between the results of this study in healthy controls and previ-
ous reports in controls and diabetics under normoxia and hy-
peroxia (100%) (3), and thus, it is unlikely that hyperoxia (66%
O2 in inspired air) was significantly contributing to the higher
lactate production seen in the diabetic rats. Hyperglycemia-
induced ketosis could be another potential confounding factor
in the metabolic phenotypes, although rarely seen in the animal
model used in this study (43); individual metabolic states could
be a contributing factor in the increased variance seen in the
diabetic rats.
In conclusion, the altered metabolic phenotype, manifested
as significantly altered oxygen sensitivity in the presence of
high intrarenal lactate levels, shows the existence of two seem-
ingly different metabolic phenotypes in the diabetic kidney,
which may highlight the need for tailored treatment strategies to
reduce the impact of diabetes on long-term kidney function.
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